Scientific publications

Frontiers in Medicine, 2026
Reanalysis of the immunological characteristics of scalp psoriasis: a cross-sectional study using Olink proteomics

Zhu L., Chen W., Shen N. et al.

Ophthalmology Science, 2026
Plasma proteomics identifies proteins and pathways associated with cataract: a prospective cohort study

Zhang Y., Yu J., Peng Y. et al.

eBioMedicine, 2026
The complement C3-microglial axis in depression of Parkinson's disease: from mechanism to therapeutic intervention

Yin Q., Ding M., Tang Y. et al.

Journal of Advanced Research, 2026
Predicting risk of mental health deterioration using multimodal data from the UK biobank

Yang S., Lv X., Huang B. et al.

Journal of the National Cancer Center, 2026
Systemic inflammatory protein signatures associated with gastric lesion progression and risk of gastric cancer

Yang L., Xu H., Zhang C. et al.

Leukemia, 2026
TP53 deficiency in AML induces resistance to T-cell engagers through an immunosuppressive secretome

Winter L., Pawlowsky L., Muth A. et al.

Pediatric Hematology and Oncology, 2026
The influence of elevated body mass index on protein expression in pediatric b-cell acute lymphoblastic leukemia

Werk R., Chacón J., Turcotte L. et al.

Ecotoxicology and Environmental Safety, 2026
Plasma proteomic signatures of long-term PM2.5 exposure and risk of incident chronic obstructive pulmonary disease

Wang X., Shen Y., Lin Z. et al.

The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2026
Decoding the delirium proteome: linking clinical vulnerabilities to acute brain dysfunction

Wang X., Liu K., Guo X. et al.

JNCI: Journal of the National Cancer Institute, 2026
Premenopausal and postmenopausal obesity and endometrial cancer risk: circulating biomarkers of inflammation, insulin resistance, and sex hormones as mediators

Wang S., Viallon V., Biessy C. et al.

Journal of Inflammation Research, 2026
Identification of Biomarker in Kidney Stone Disease by Integrating Transcriptomics and Olink Proteomics: A Case–Control Study

Wang N., Zhou B., Xu C. et al.

European Journal of Pharmacology, 2026
Long non-coding RNA TTN-AS1 promotes acute liver injury in sepsis: A novel potential monitoring and therapeutic target

Wang J., Yan Y., Wang C. et al.

Translational Psychiatry, 2026
An integrative mendelian randomisation and drug mechanism framework for target prioritisation and therapeutic repurposing in major depression

ter Kuile A., Finan C., Chopade S. et al.

Psychiatry Research, 2026
Multi-omics integration identifies cell-type-specific CISD1 and QDPR as druggable regulators linking hepatocellular carcinoma and major depressive disorder

Sun L., Bi J., Sun J.

Cell Death & Differentiation, 2026
Cell death–induced release of the pro-aging protein acyl CoA binding protein (ACBP) into the circulation

Rong Y., Lambertucci F., Yang Y. et al.

Neuro-Oncology Advances, 2026
Differential modulation of glioma metabolism and the tumor microenvironment following dexamethasone and bevacizumab treatment

Maise L., Krautwurst F., Surender S. et al.

Journal of Global Health, 2026
Plasma proteomic signatures predict incident benign prostatic hyperplasia: a prospective cohort study of 20 996 men

Li H., Zhang Y., Chen L. et al.

Clinica Chimica Acta, 2026
Emerging biomarkers in IgA nephropathy, membranous nephropathy, and lupus nephritis

Kobayashi H., Murata Y., Akiya Y. et al.

Annals of the Rheumatic Diseases, 2026
Longitudinal profiling reveals immune dynamics and distinct plasma cell signatures during B-cell depletion in IgG4-related disease

Kim H., Kim M., Kim S. et al.

Human Mutation, 2026
CLEC4G Promotes Pancreatic Cancer Progression by Suppressing Cathepsin B‐Mediated Ferroptosis: Evidence From Mendelian Randomization Study and Experimental Validation

Jiang Z., Ma P., Zhang S. et al.